Menu

Spotlight Sessions

Friday, November 3, 2017

12:00pm – 1:30pm
  • Clinical SRS/SBRT Primer for Residents

    This session will serve as a primer for the indications, techniques, and current evidence for SRS/SBRT in the clinic. It will include discussions on the radiobiology of hypofractionated treatment and the applications of SRS/SBRT for spine, lung, prostate, and GI malignancies.

12:00pm – 1:30pm
  • Physics SRS/SBRT Primer for Residents

    This session will serve as a primer for the indications, techniques, and current evidence for SRS/SBRT in the clinic. It will include discussions on the various treatment modalities, treatment planning considerations, and quality assurance.

4:30pm – 6:00pm
  • Nurse & Therapist Session: Why We Do What We Do …and More

    This session is targeted to all nurses and therapist interested in increasing their knowledge with treating patients with SRS/SBRT and targeted therapies. Topics to include: rationale and appropriate timing of SRS/SBRT delivery, challenges related to delivery of SRS/SBRT in bariatric and pancreatic patient population, long-term side effects, and the future of SBRT.

6:00pm – 7:30pm
  • Poster Walk with a Professor (Residents only)

    Experts in clinical radiation oncology and radiation physics will lead groups of residents through the displayed posters and highlight several posters of their choosing.

    You will be able to sign up with specific professors closer to the meeting time.

Saturday, November 4, 2017

8:00am – 10:00am
  • Performance & Quality Improvement Session (PQIS)

    The Performance & Quality Improvement Session (PQIS) is an interactive forum allowing meeting attendees to present and review complex and challenging SRS/SBRT cases, encouraging peer-to-peer discussions, and exchange of experiences and opinions.

    Expert Panel:

    • John J. Kresl, MD, PhD, DABR, FACRO, FACR, Radiation Oncologist of Central Arizona (ROCA), Phoenix, AZ
    • Richard Bucholz, MD, FACS, St. Louis University, St. Louis, MO
    • Christoph Fürweger, PhD, European CyberKnife Center, Munich Germany
    • Tim Solberg, PhD, UCSF, San Francisco, CA
    • Rachelle Lanciano, M.D., Philadelphia CyberKnife, Havertown, PA

    The session will follow the traditional Radiosurgery Society Meeting PQIS format. Participants are encouraged to submit interesting and/or challenging case studies using the provided PowerPoint template. Submitted cases will be reviewed and scored by an SRS/SBRT expert panel. Key cases will be identified and invited to present during this session. The sharing of experience amongst practitioners always creates a lively and active discussion with the main objective of improving patient treatment, safety and care.

    ELIGIBILITY CRITERIA

    1. Case Study
      • A minimum of one (1) case study submitted per facility is sufficient to admit all members of that facility.
      • Presentation must conform to HIPAA standards; presentation limited to 7 minutes followed by 8 minutes active discussion with audience and expert panel.
    2. New Users
      • Users new to SRS/SBRT (with less than 6 months SRS/SBRT patient treatment experience) are welcome to attend the PQIS without presenting a case study.
    3. Conference Participation and Confidentiality
      • All participants must fulfill the above eligibility criteria and sign a Conference Participation and Confidentiality Agreement (available onsite).
      • This session is NOT open to corporate vendors or those not fulfilling eligibility criteria.

    DOWNLOAD PQIS TEMPLATE

    For any question regarding abstract submission, please contact Jan Jenkins at jjenkins@therss.org.

    CASE SUBMISSION DEADLINE: October 1, 2017

Commercial vendors /exhibitors will not have access to this session. All PQIS attendees MUST sign a Confidentiality Agreement prior to admittance to the session.
sponsored by
10:30am – 12:00pm
  • SBRT for Lung Cancer – Dosimetry Plan Study

    The Radiosurgery Society (RSS) and ProKnow are proud to launch two exciting quality studies dedicated to SBRT treatment of lung cancer. These studies are now open and accepting submissions through Friday, October 13, 2017.

    Sign In (or Register) to Start Planning

    PLAN QUALITY STUDY

    A challenging SBRT plan has been designed by the team of clinical experts, where 23 total quality metrics (21 of them scored) will be extracted and formulated into a composite plan quality score using the patented PlanIQ™ method. As always with ProKnow Plan Studies, participants can score and analyze their results interactively and with unlimited attempts to improve the score until the submission deadline.

    CONTOURING STUDY

    Four critical organs-at-risk (OAR) have been contoured by the expert team. Participants can use the online ProKnow contouring tools to contour the:

    • Esophagus
    • Large vessels
    • Proximal bronchial tree
    • Trachea

    Each participant can get immediate results of their contours vs. the expert contours as a quantified StructSure™ score and Dice coefficient, with interactive color display of regions of agreement and differences.

    Population results – including a “heat map” showing regions of agreement across all participants – will be released after the RSS presentation on the “Population Results” tab for each structure.

    MEET OUR TEAM OF CLINICAL EXPERTS

    Drew Moghanaki, MD, MPH
    VCU Massey Cancer Center, Richmond, VA

    Ben J. Slotman, MD, PhD
    Vrije Universiteit Medical Center, Amsterdam, the Netherlands

    Anand Swaminath, MD, MSc, FRCPC
    Juravinski Cancer Centre, Ontario, Canada

    Brian Wang, PhD
    University of Louisville, Louisville, KY

    • This session is open to all registrants of the Scientific Meeting, including our commercial vendors/exhibitors who are generously supporting this meeting.
    • The link to the Lung Dosimetry Plan Study will be posted on the RSS website and available to download/plan/upload from September 1 – October 13, 2017.

    Your team could win an amazing prize!

1:00pm – 2:30pm
LECTURE SERIES

2:30pm – 4:30pm
PRACTICAL SESSION

  • Advances in the Management of Brain Metastases

    Obtain knowledge on the clinical application and technical aspects of SRS and other advanced targeted therapies in the treatment of multiple brain metastases pre-op and post-op. 

    Didactic: SRS and Advances in Targeted Therapy for Brain Metastases

    • "Pre-operative vs. Post-operative Radiosurgery for Brain Metastases' " - Scott Soltys, MD
    • "Managing Multiple Brain Metastases with SRS. How Many Metastases is Crazy?" - John Flickinger, MD, FACR, University of Pittsburgh Medical Center
    • "Multimodal Treatment Strategies in the Management of Complex and Recurrent Intracranial Metastatic Tumors" - Susan Pannullo, MD, New York Presbyterian/Weill Cornell Medical Center
    • "Integrating Systemic Therapy and Radiosurgery" - John Fiveash, MD University of Alabama
    • "Leveraging Immunotherapy for Brain Metastases" - Chandan Guha, MBBS, PhD, Albert Einstein College of Medicine

    Practical: Case Review, Lecture, Tips and Tricks, Treatment Planning Platforms showcasing optimal plans. Cases pre-loaded on a variety of Treatment Planning Stations

    Opens Session: Helen Shih, MD, Associate Medical Director - Francis H. Burr Proton Therapy Center, MGH Associate Program Director - Harvard Radiation Oncology Residency Program, Director, CNS Service

    • Four or more metastases
    • Brain Metastases near or involving critical structures
    • Post-Op SRS of the resection cavity

    Prices:
    Didactic Session: No charge to attend
    Practical Session: $49.00 for RSS Members and $79.00 for non-RSS Members

    * CE, CME, and SAM credits for the entire 3.5 hours is under review
    Subject to change.

Lecture Series: No charge to attend
Practical Session: $49 for RSS members; $79 for non-RSS members